Predict your next investment

My Intelligent Machines company logo
INTERNET | Internet Software & Services / Scientific, Engineering
mims.ai

See what CB Insights has to offer

Founded Year

2016

Stage

Series A | Alive

Total Raised

$6.67M

Last Raised

$3.99M | 6 mos ago

About My Intelligent Machines

My Intelligent Machines is a platform as a service helping biologists analyze genomic data using AI. The platform finds the appropriate algorithms to analyze the user's data and generates text on its methods of analysis.

My Intelligent Machines Headquarter Location

51 Sherbrooke street West Office 101

Montreal, Quebec, H2X 1X2,

Canada

438-375-1269

Latest My Intelligent Machines News

My Intelligent Machines Receives the Company of the Year 2021 Award Granted by Anges Québec

Jun 8, 2021

June 08, 2021 12:00 PM Eastern Daylight Time MONTREAL--( BUSINESS WIRE )--My Intelligent Machines (“MIMs”), a leader in artificial intelligence and systems biology, today announced it has received the Company of the Year 2021 Award by Anges Québec, during their 2021 Annual Gathering which brought together virtually close to 175 participants on June 3rd. MIMs especially stood out thanks to the disruptive innovation at the core of its augmented intelligence software solution, supporting R&D activities applied to life sciences. MIMs’ public outreach along with industry recognition have been underlined, as well as the company’s emphasis on women leadership. “At MIMs, we see inclusion and gender equity as an engine supporting our growth, humanist values and innovations,” explains Sarah Jenna, CEO and co-founder of MIMs. “My co-founders, Mickaël Camus and Abdoulaye Baniré Diallo, and I are honoured to be recognized by Anges Québec. We would like to thank our outstanding team that develops pioneering AI solutions, designed to shift paradigms in the fields of precision medicine and agriculture, as well as our investors and angels from Anges Québec, for their continued trust and input over the past four years.” The 2021 Annual Gathering organized by Anges Québec also highlighted the performance of Patrick Sauvageau, CEO and co-founder of Zilia, as Investment of the year and the contribution of Donald Clarke as Angel of the year. MIMs warmly congratulates them for their respective awards. About MIMs’ SaaS solutions MIMs markets augmented intelligence systems packaged in a software-as-a-service (SaaS) solution, to support patient stratification and the selection of therapeutic targets and biomarkers, both required for the development of more efficient and personalized therapies. Whereas conventional AI solutions generally operate as a ‘black box’, MIMs’ software solutions are based on open and explainable AI and data integration. Augmented intelligence empowers scientists and their machines to identify together what neither could have done individually. Creating a synergy between the machine and its users enables life scientists to capitalize on machine-based computer modelling, distributed computing and federated learning, while leveraging their own expertise in life sciences, in order to understand complex biological systems more precisely than ever before. Founded in 2016, Montreal-based My Intelligent Machines (MIMs) is a leader in artificial intelligence and systems biology. MIMs provides Biopharma and Agtech companies with easy-to-implement augmented intelligence systems, allowing for accurate biological simulations at early R&D stages, to assist life scientists in the development of targeted and personalized therapies. MIMs will continue to expand in Canada, the United States and Europe.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing My Intelligent Machines

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned My Intelligent Machines in 1 CB Insights research brief, most recently on Sep 6, 2019.

Expert Collections containing My Intelligent Machines

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

My Intelligent Machines is included in 6 Expert Collections, including Genomics.

G

Genomics

823 items

Companies involved in the capture, sequencing, and/or analysis of genetic data

A

Artificial Intelligence ( AI ) in Healthcare

826 items

These healthcare startups are using AI to discover new drugs, remotely monitor patients, securely transfer patient data, and more.

C

Clinical Trials Tech

317 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.

A

Artificial Intelligence

7,895 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

O

Omics

1,029 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

D

Digital Health

11,260 items

Companies leveraging digital technology for healthcare, consumer health, clinical research, and life science (e.g. biopharma, medtech) applications.

My Intelligent Machines Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

My Intelligent Machines Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.